Intravesical chemotherapy in BCG waiting period may prolong time to recurrence for high-risk NMIBC patients

Abstract Purpose This study aimed to determine whether administering intravesical chemotherapy (IVC) during the Bacillus Calmette - Guérin (BCG) waiting period after the second TURBT improves the recurrence-free survival (RFS) of patients with non - muscle - invasive bladder cancer (NMIBC). Methods...

Full description

Bibliographic Details
Published in:BMC Cancer
Main Authors: Zhen Li, Zewei Wang, Jiyue Wu, Feilong Zhang, Lijian Gan, Wei Wang, Hailong Li, Ling Gu
Format: Article
Language:English
Published: BMC 2025-02-01
Subjects:
Non–muscle-invasive bladder cancer
TURBT
BCG
Chemotherapy
Recurrence
Online Access:https://doi.org/10.1186/s12885-025-13705-z

Internet

https://doi.org/10.1186/s12885-025-13705-z

Similar Items